SE8302347L - BENSOAZACYCLOYLKYL-SPIRO-IMIDAZOLIDINES, PREPARING THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM - Google Patents

BENSOAZACYCLOYLKYL-SPIRO-IMIDAZOLIDINES, PREPARING THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Info

Publication number
SE8302347L
SE8302347L SE8302347A SE8302347A SE8302347L SE 8302347 L SE8302347 L SE 8302347L SE 8302347 A SE8302347 A SE 8302347A SE 8302347 A SE8302347 A SE 8302347A SE 8302347 L SE8302347 L SE 8302347L
Authority
SE
Sweden
Prior art keywords
bensoazacycloylkyl
imidazolidines
spiro
preparing
pharmaceutical compositions
Prior art date
Application number
SE8302347A
Other languages
Swedish (sv)
Other versions
SE8302347D0 (en
Inventor
C Malen
J-L Peglion
J Duhault
M Boulanger
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of SE8302347D0 publication Critical patent/SE8302347D0/en
Publication of SE8302347L publication Critical patent/SE8302347L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

The present invention provides a compound of the general formula: <IMAGE> in which - R1 represents a halogen or a hydrogen atom, or a hydroxy or methoxy group, - R2 represents a hydrogen atom, a lower alkyl radical, a phenyl-lower alkyl radical, a lower alkanoyl radical or a p-toluenesulphonyl group, and - n represents 1 or 2, in the racemic form or as an optical isomer, or salts thereof and a process for their preparation. These compounds are useful in the treatment of diabetes.
SE8302347A 1982-04-27 1983-04-26 BENSOAZACYCLOYLKYL-SPIRO-IMIDAZOLIDINES, PREPARING THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SE8302347L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8207203A FR2525603A1 (en) 1982-04-27 1982-04-27 BENZOAZACYCLOALKYL-SPIRO-IMIDAZOLININES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Publications (2)

Publication Number Publication Date
SE8302347D0 SE8302347D0 (en) 1983-04-26
SE8302347L true SE8302347L (en) 1983-10-28

Family

ID=9273425

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8302347A SE8302347L (en) 1982-04-27 1983-04-26 BENSOAZACYCLOYLKYL-SPIRO-IMIDAZOLIDINES, PREPARING THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Country Status (22)

Country Link
JP (1) JPS5910584A (en)
KR (1) KR840004428A (en)
AT (1) ATA125383A (en)
AU (1) AU1395383A (en)
BE (1) BE896572A (en)
DD (1) DD209833A5 (en)
DE (1) DE3315106A1 (en)
DK (1) DK183583A (en)
ES (1) ES521895A0 (en)
FR (1) FR2525603A1 (en)
GB (1) GB2133401B (en)
GR (1) GR78481B (en)
IL (1) IL68497A0 (en)
IT (1) IT1167123B (en)
LU (1) LU84770A1 (en)
MA (1) MA19783A1 (en)
NL (1) NL8301476A (en)
NO (1) NO831473L (en)
OA (1) OA07412A (en)
PT (1) PT76595B (en)
SE (1) SE8302347L (en)
ZA (1) ZA832927B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU617541B2 (en) * 1988-10-20 1991-11-28 Wyeth Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US4927831A (en) * 1988-10-20 1990-05-22 American Home Products Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
EA016558B1 (en) 2003-06-17 2012-05-30 Арена Фармасьютикалз, Инк. Benzazepine derivatives useful for the treatment of 5htreceptor associated diseases
MXPA05013364A (en) 2003-06-17 2006-03-17 Arena Pharm Inc Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases.
JP5270167B2 (en) 2004-12-21 2013-08-21 アリーナ ファーマシューティカルズ， インコーポレイテッド Crystalline form of (R) -8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
SG158168A1 (en) 2004-12-23 2010-01-29 Arena Pharm Inc 5ht2c receptor modulator compositions and methods of use
WO2007120517A2 (en) 2006-04-03 2007-10-25 Arena Pharmaceuticals, Inc. Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates related thereto
JP5404414B2 (en) 2006-12-05 2014-01-29 アリーナ ファーマシューティカルズ， インコーポレイテッド Method for preparing (R) -8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and its intermediates
WO2009111004A1 (en) 2008-03-04 2009-09-11 Arena Pharmaceuticals, Inc. Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine
WO2010148207A2 (en) 2009-06-18 2010-12-23 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-ht2c receptor agonists
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
WO2012030938A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Salts of lorcaserin with optically active acids
KR101913442B1 (en) 2010-09-01 2018-10-30 에자이 알앤드디 매니지먼트 가부시키가이샤 Modified-release dosage forms of 5-ht2c agonists useful for weight management
WO2012030939A1 (en) 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Administration of lorcaserin to individuals with renal impairment
MX2013002421A (en) 2010-09-01 2013-05-17 Arena Pharm Inc Non-hygroscopic salts of 5-ht2c agonists.
AU2012392187B2 (en) 2012-10-09 2018-07-12 Arena Pharmaceuticals, Inc. Method of weight management

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4209630A (en) * 1976-10-18 1980-06-24 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives

Also Published As

Publication number Publication date
JPS5910584A (en) 1984-01-20
ATA125383A (en) 1986-05-15
DD209833A5 (en) 1984-05-23
MA19783A1 (en) 1983-12-31
AU1395383A (en) 1983-11-03
DK183583D0 (en) 1983-04-26
DK183583A (en) 1983-10-28
IL68497A0 (en) 1983-07-31
IT1167123B (en) 1987-05-13
FR2525603B1 (en) 1984-09-14
GB2133401B (en) 1985-10-23
ES8405796A1 (en) 1984-06-16
ZA832927B (en) 1984-06-27
KR840004428A (en) 1984-10-15
LU84770A1 (en) 1984-11-28
GB2133401A (en) 1984-07-25
PT76595A (en) 1983-05-01
SE8302347D0 (en) 1983-04-26
GB8311508D0 (en) 1983-06-02
NO831473L (en) 1983-10-28
IT8348155A0 (en) 1983-04-26
NL8301476A (en) 1983-11-16
GR78481B (en) 1984-09-27
ES521895A0 (en) 1984-06-16
BE896572A (en) 1983-10-26
FR2525603A1 (en) 1983-10-28
DE3315106A1 (en) 1983-11-03
OA07412A (en) 1984-11-30
PT76595B (en) 1986-01-21

Similar Documents

Publication Publication Date Title
SE8302347L (en) BENSOAZACYCLOYLKYL-SPIRO-IMIDAZOLIDINES, PREPARING THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
HK57197A (en) Naphthalene derivatives procedure for their preparation and pharmaceutical compositions containing them
IL101819A0 (en) Amidinophenylalanine derivatives,a process for the preparation thereof,use thereof and agents containing these as anticoagulants
DK161382C (en) PROCEDURE FOR PREPARING 1,2,4-TRIAZOL COMPOUNDS OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS
ATE41772T1 (en) POLYMETHOXYBENZYL PIPERAZINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES.
ES8407033A1 (en) Benzothiazoline compounds
IL79910A0 (en) Tricyclic compounds,process for the preparation thereof and pharmaceutical compositions containing the same
ATE37533T1 (en) DERIVATIVES OF 4-PHENYL-4-OXO-BUTENE-2-ACID, PROCESS FOR THEIR PREPARATION, MEDICATIONS AND MIXTURES WITH THESE DERIVATIVES.
JPS57126441A (en) Novel cinnamoylcinnamic acid derivative, manufacture and therapeutical composition containing same
SE8304410D0 (en) CYCLOHEXYLCARBOXYLIC ACID DERIVATIVES AND SETS FOR THEIR PREPARATION
FI821288L (en) PHENETHANOLAMIN DERIVATIVES, DERAS FRAMSTAELLNING OCH DERAS TERAPEUTISKA ANVAENDNING
GR3003656T3 (en)
ZA84261B (en) Bicyclo(4.2.0)1,3,5-octatriene derivatives,a process for their preparation and pharmaceutical compositions containing them
ES2067710T3 (en) NON-IONIZED IODINE COMPOUNDS, THEIR PREPARATION PROCEDURE AND CONTRAST PRODUCTS CONTAINING THEM.
IL76652A0 (en) Thiadiazole derivatives,their preparation and pharmaceutical compositions containing them
DE3062417D1 (en) Process for regulating plant growth
DE3363575D1 (en) Furyloxazolylacetic acid derivatives, process for preparing same and pharmaceutical compositions containing same
SE8903313L (en) NEW 2-METOXICARBONYL-SUBSTITUTED N, N&#39;-DI- (TRIMETOXYBENZOYL) -PIPERAZINES, PROCEDURES FOR PREPARING THEREOF AND THERAPEUTIC SUBSTANCES CONTAINING THEM
ATE6063T1 (en) CYCLOALKANOTHIAZOLYLOXAMID ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC AGENTS CONTAINING THEM.
PT78364A (en) Process for preparing iminosulphonamides from pharmaceutic preparation wich contain these compounds and its therapeutical utilization
SE7907656L (en) 3,4-DIHYDROXIKANELALDEHYDDERIVAT
ES484086A1 (en) Isopropyl amine derivatives, processes for their preparation and medicaments containing them.
ES506947A0 (en) IMPROVEMENTS INTRODUCED IN A PROCEDURE FOR THE PREPARATION OF HYDROXYMIDATE AND THYL HYDROXYMIDATE HETEROBICICLICOS AND DERIVATED ESTER CARBOMATES.
ES2013316A6 (en) A process for preparing a guanidinothiazole derivative
SE7806445L (en) ALKANOLAMINE DERIVATIVES AND THEY OF THEIR PREPARATION

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8302347-3

Format of ref document f/p: F